Drugs / Mineral Trioxide Aggregate
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| — | NCT05850780 Comparator | Dec 2022 → Jun 2024 | pulpitis | Aliaa Hamouda | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Mineral Trioxide Aggregate | “Mineral Trioxide Aggregate (MTA)” NCT05850780 ↗ |
| Known as | MTA | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05850780 ↗ |